CLINICAL-EVALUATION OF THE BISPECIFIC ANTIBODY MDX-H210 (ANTI-FC-GAMMA-RI-X-ANTI-HER-2 NEU) IN COMBINATION WITH GRANULOCYTE-COLONY-STIMULATING FACTOR (FILGRASTIM) FOR TREATMENT OF ADVANCED BREAST-CANCER/

Authors
VANOJIK HH REPP R GROENEWEGEN G VALERIUS T VANDEWINKEL JGJ
Citation
Hh. Vanojik et al., CLINICAL-EVALUATION OF THE BISPECIFIC ANTIBODY MDX-H210 (ANTI-FC-GAMMA-RI-X-ANTI-HER-2 NEU) IN COMBINATION WITH GRANULOCYTE-COLONY-STIMULATING FACTOR (FILGRASTIM) FOR TREATMENT OF ADVANCED BREAST-CANCER/, Cancer immunology and immunotherapy, 45(3-4), 1997, pp. 207-209
Citations number
21
Categorie Soggetti
Immunology,Oncology
Journal title
Cancer immunology and immunotherapy → ACNP
ISSN journal
03407004
Volume
45
Issue
3-4
Year of publication
1997
Pages
207 - 209
Database
ISI
SICI code
0340-7004(1997)45:3-4<207:COTBAM>2.0.ZU;2-D